You are here: Home » Markets » News
Sun Pharma climbs over 5% on deal with AstraZeneca, pares gains later
Business Standard

Nilekani assures action if whistleblower allegations proved; Infosys up 2%

Backing Parekh, the chairman of the IT bellwether said that he would give full credit to the CEO for the company's growth.

Topics
Buzzing stocks | Infosys  | Nandan Nilekani

SI Reporter  |  New Delhi 



Infosys plans less staff deployment to meet future demands, check attrition

Ltd advanced up to 3.7 per cent to Rs 721.50 apiece in the intra-day trade on the BSE on Wednesday after the non-executive chairman Nandan Nilekani, during the company's concall, told investors that the company would take action if the allegations against it are substantiated.

The stock eventually settled at Rs 712, up over 2 per cent on the BSE.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Wed, November 06 2019. 12:00 IST

RECOMMENDED FOR YOU

.